166 related articles for article (PubMed ID: 18252754)
1. Measles vaccination and antibody response in autism spectrum disorders.
Baird G; Pickles A; Simonoff E; Charman T; Sullivan P; Chandler S; Loucas T; Meldrum D; Afzal M; Thomas B; Jin L; Brown D
Arch Dis Child; 2008 Oct; 93(10):832-7. PubMed ID: 18252754
[TBL] [Abstract][Full Text] [Related]
2. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.
Halsey NA; Hyman SL;
Pediatrics; 2001 May; 107(5):E84. PubMed ID: 11331734
[TBL] [Abstract][Full Text] [Related]
3. Response to measles-mumps-rubella vaccine in children with autism spectrum disorders.
Gentile I; Bravaccio C; Bonavolta R; Zappulo E; Scarica S; Riccio MP; Settimi A; Portella G; Pascotto A; Borgia G
In Vivo; 2013; 27(3):377-82. PubMed ID: 23606694
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
Mrozek-Budzyn D; Kiełtyka A; Majewska R
Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of measles antibodies in children with autism.
Singh VK; Jensen RL
Pediatr Neurol; 2003 Apr; 28(4):292-4. PubMed ID: 12849883
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
7. Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism.
Singh VK; Lin SX; Newell E; Nelson C
J Biomed Sci; 2002; 9(4):359-64. PubMed ID: 12145534
[TBL] [Abstract][Full Text] [Related]
8. No evidence for a new variant of measles-mumps-rubella-induced autism.
Fombonne E; Chakrabarti S
Pediatrics; 2001 Oct; 108(4):E58. PubMed ID: 11581466
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
10. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder.
D'Souza Y; Fombonne E; Ward BJ
Pediatrics; 2006 Oct; 118(4):1664-75. PubMed ID: 17015560
[TBL] [Abstract][Full Text] [Related]
11. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK.
Afzal MA; Ozoemena LC; O'Hare A; Kidger KA; Bentley ML; Minor PD
J Med Virol; 2006 May; 78(5):623-30. PubMed ID: 16555271
[TBL] [Abstract][Full Text] [Related]
12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
13. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
14. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
[TBL] [Abstract][Full Text] [Related]
15. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
Kontio M; Jokinen S; Paunio M; Peltola H; Davidkin I
J Infect Dis; 2012 Nov; 206(10):1542-8. PubMed ID: 22966129
[TBL] [Abstract][Full Text] [Related]
16. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
Vaccine; 2012 Jun; 30(28):4292-8. PubMed ID: 22521285
[TBL] [Abstract][Full Text] [Related]
17. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism.
Jain A; Marshall J; Buikema A; Bancroft T; Kelly JP; Newschaffer CJ
JAMA; 2015 Apr; 313(15):1534-40. PubMed ID: 25898051
[TBL] [Abstract][Full Text] [Related]
18. An epidemiological study on Japanese autism concerning routine childhood immunization history.
Takahashi H; Suzumura S; Shirakizawa F; Wada N; Tanaka-Taya K; Arai S; Okabe N; Ichikawa H; Sato T
Jpn J Infect Dis; 2003 Jun; 56(3):114-7. PubMed ID: 12944678
[TBL] [Abstract][Full Text] [Related]
19. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
20. MMR vaccine and autism: a review of the evidence for a causal association.
DeStefano F
Mol Psychiatry; 2002; 7 Suppl 2():S51-2. PubMed ID: 12142951
[No Abstract] [Full Text] [Related]
[Next] [New Search]
